600129.SS · 太极集团
China A-shares · RS rating 26 · As of 2026-10-14
| Price | 13.53 CNY |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 26 / 64 / 30 / 17 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 19 / 19 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +1.1% |
| Distance from 52-week high | +39.5% |
| Market cap (USD) | $1.1B |